20 studies found for:    Cad106
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Condition: Alzheimer's Disease
Intervention: Biological: CAD106
2 Completed To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
Condition: Alzheimer Disease
Intervention: Biological: CAD106
3 Completed Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients
Condition: Alzheimer's Disease
Interventions: Biological: Placebo;   Biological: CAD106
4 Completed To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
Condition: Alzheimer Disease
Intervention: Biological: CAD106
5 Completed Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Biological: CAD106;   Drug: Placebo
6 Completed Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.
Condition: Alzheimer Disease
Interventions: Biological: Placebo;   Biological: CAD106
7 Recruiting BIOFLOW III Asia Registry
Conditions: Coronary Artery Disease;   Myocardial Ischemia;   Diabetes Mellitus Type 1 or 2
Intervention:
8 Completed Virtual Coronary Intervention and Non-invasive Fractional Flow Reserve (FFR)
Condition: Coronary Artery Disease
Intervention:
9 Recruiting Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets
Condition: Coronary Artery Disease
Intervention: Device: platinum chromium everolimus-eluting stent (PROMUS Element by Boston Scientific, Massachusetts)
10 Terminated Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
Condition: Coronary Artery Disease
Interventions: Drug: Apadenoson SPECT-MPI;   Drug: Adenosine SPECT-MPI
11 Unknown  Could Non-invasive Biochemical, Image or Physiological Index Predict Significant Coronary Arterial Stenosis in Symptomatic Adults?
Condition: Coronary Heart Disease
Interventions: Radiation: coronary calcium score measurement;   Biological: high sensitivity C reactive protein measurement;   Procedure: ankle brachial index measurement
12 Completed Computed Tomography Angiography Prediction Score for Percutaneous Revascularization of Chronic Total Occlusions
Condition: Coronary Artery Disease
Intervention: Procedure: PCI of CTO
13 Active, not recruiting The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Plus;   Device: SYNERGY
14 Active, not recruiting
Has Results
RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent
Conditions: Arterial Occlusive Diseases;   Myocardial Ischemia;   Cardiovascular Diseases;   Coronary Artery Disease
Intervention: Device: MDT-4107 Drug Eluting Stent
15 Completed Endocardial Stem Cells Approach Efficacy
Condition: Myocardial Ischemia
Intervention: Procedure: Autologous bone marrow mononuclear stem cells or peripheral blood stem cells
16 Completed Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
Conditions: Myocardial Infarction;   Coronary Artery Disease
Intervention: Drug: Intra-coronary infusion
17 Completed Rotational Atherectomy Prior to Taxus Stent
Condition: Complex Calcified Coronary Lesions
Interventions: Procedure: Rotational Atherectomy + PES;   Procedure: Standard Treatment (PES without Rotational Atherectomy)
18 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
19 Completed TomVasc - Vascular Effects of Tomato Extract
Conditions: Ischemic Heart Disease;   Transient Ischemic Attack;   Stroke;   Peripheral Vascular Disease
Interventions: Dietary Supplement: Ateronon;   Dietary Supplement: Placebo
20 Active, not recruiting Mesenchymal Stem Cells and Myocardial Ischemia
Conditions: Chronic Myocardial Ischemia;   Left Ventricular Dysfunction
Intervention: Genetic: Mesenchymal stem cells

Indicates status has not been verified in more than two years